For children with short stature and rare genetic growth disorders, hope is on the horizon at Children’s National Hospital. Andrew Dauber, MD, MMSc, chief of Endocrinology, and Nathan Kuppermann, MD, MPH, chair of Pediatrics and chief academic officer, sat down to discuss groundbreaking research transforming the field. Hear about the world’s first clinical trial of vosoritide for hypochondroplasia, led by Dr. Dauber, and the design of a precision medicine trial for a single patient. Dr. Dauber and his team are uncovering genetic causes and developing targeted treatments. Learn how these breakthroughs are reshaping pediatric endocrinology and offering new possibilities for families worldwide.

Listen via Apple, Audacy, iHeart Radio and Spotify, or wherever you get your podcasts.